Company: SCLXW
Filing Date: 2025-05-14
Form Type: 424B3
Source: 0001193125-25-119831
Chunk: 170

Company: Scilex Holding Co
Filing Date: 2025-05-14
Form: 424B3
Chunk 170
---
, publications, surveys and other data obtained from
third-party sources and our own internal estimates and research. While we believe these third-party sources to be reliable as of the date of this prospectus, we have not independently verified the market and industry data contained in this
prospectus or the underlying assumptions relied on therein. Finally, while we believe our own internal research is reliable, such research has not been verified by any independent source. Notwithstanding the foregoing, we are liable for the
information provided in this prospectus. The industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the section of this prospectus titled “Risk Factors.” These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us.

104

USE OF PROCEEDS

We will receive no proceeds from the sale of the Resale Shares by the Selling Stockholder. The Selling Stockholder will pay any underwriting
discounts, selling commissions or transfer taxes incurred in disposing of the Resale Shares and the expenses of any attorney or other advisor they decide to employ. We will bear all other costs, fees and expenses incurred in effecting the
registration of the Resale Shares covered by this prospectus. These may include, without limitation, all registration, filing, stock exchange fees, printing expenses, all fees and expenses of complying with applicable securities laws and the fees
and disbursements of our counsel and of our independent accountants and reasonable fees.

To the extent the Penny Warrants are exercised
for cash, if at all, we will receive the exercise price of any such exercise of the Penny Warrants, but will not receive any proceeds from the sale of the shares of our Common Stock issuable upon such exercise. If all of the remaining Penny Warrants
were exercised, we would receive gross proceeds of $65,000. However, the holders of the Penny Warrants are not obligated to exercise the Penny Warrants and we cannot predict whether or when, if ever, the holders of the Penny Warrants will choose to
exercise the Penny Warrants, in whole or in part. Each Penny Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $0.01 per share.

We currently intend to use the proceeds (if any) from the exercise of the Penny Warrants for cash for working capital and general corporate
purposes, which may include capital expenditures, commercialization expenditures,